CRT 2026

Discussion

Moderator(s)

• 

  Michael J. Bloch, MD

  Medical Director, Vascular Care
  Renown Institute for Heart and Vascular Health
  reno, Nevada, United States

  Disclosure(s): Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Coravie: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); mineralyx: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); novartis: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

• 

  Joost Daemen, MD, PhD

  Interventional Cardiologist
  Erasmus MC Thoraxcenter
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure information not submitted.
• DL

  David P. Lee, MD

  Professor of Medicine
  Stanford University
  Stanford, California, United States

  Disclosure information not submitted.